Material Event Report (Treasury Stock Acquisition Decision)
6.3
에스디바이오센서 주식회사
Amendment Filing (Report)
| 1. Disclosure being amended: | 주요사항보고서 |
| 2. Original filing date of amended disclosure: | 2026-11-10 |
| Item | Reason for amendment | Before amendment | After amendment |
| 3. Expected Acquisition Period | 단순오기 | 시작일 : 2026-11-11종료일 : 2026-02-10 | 시작일 : 2026-11-11종료일 : 2027-02-10 |
Material Event Report / KRX Mandatory Disclosure
| To: Financial Services Commission / Korea Exchange | 2026-11-10 |
| Company Name: | 에스디바이오센서 주식회사 |
| CEO: | 이 효 근 |
| Head Office Address: | 경기도 수원시 덕영대로 1556번길 16, 씨동 4층, 5층 |
| (Tel) 031-300-0400 |
| (홈페이지) http://www.sdbiosensor.com |
| Preparer: | (직 책) 상 무 | (성 명) 유 호 경 |
| (Tel) 031-300-0400 |
Decision on treasury stock acquisition
| 1. Shares to Be Acquired (shares) | Common Shares | 1,954,888 |
| Other Shares | - |
| 2. Planned Acquisition Amount (KRW) | Common Shares | 13,000,005,200 |
| Other Shares | - |
| 3. Expected Acquisition Period | Start Date | 2026-11-11 |
| End Date | 2027-02-10 |
| 4. Expected Holding Period | Start Date | - |
| End Date | - |
| 5. Purpose of Acquisition | 자기주식 취득을 통한 주주환원정책 이행 및 주주가치 제고 |
| 6. Acquisition Method | 유가증권시장을 통한 직접취득 |
| 7. Entrusted Investment Broker | NH투자증권(NH Investment & Securities Co.,Ltd.) |
| 8. Treasury Shares Held Before Acquisition | Acquisition within distributable profits (shares) | Common Shares | 1,129,750 | Ratio (%) | 0.94 |
| Other Shares | - | Ratio (%) | - |
| Other Acquisitions (shares) | Common Shares | 137 | Ratio (%) | 0.00 |
| Other Shares | - | Ratio (%) | - |
| 9. Acquisition Resolution Date | 2026-11-10 |
| - Independent (Outside) Directors* Present | Present (persons) | 3 |
| Absent (persons) | 1 |
| - Auditor (audit committee member not an independent (outside) director*) attendance | - |
| 10. Daily Purchase Order Limit (1 days) | Common Shares | 195,488 |
| Other Shares | - |
* Independent directors for listed companies; outside directors for unlisted companies
| 11. Other Matters Relevant to Investment Decisions |
- 본 건은 당사가 2026-03-10 공시한 '수시공시의무관련사항(공정공시)'에 따라 주주가치 제고 목적으로 추진하는 주주환원정책 이행 사항입니다. - 상기 '1. 취득예정주식(주)'은 2. 취득예정금액(원)을 이사회 결의일 직전 거래일 종가(2026.11.09./6,650원)를 기준으로 산정한 수량으로, 향후 주가 변동에 따라 실제 취득 주식수 및 취득 금액은 변동될 수 있습니다. - 상기 '4. 보유예상기간' 관련하여, 당사는 자기주식 취득 완료 이후 취득한 주식을 당사 주주환원 정책에 따라 소각할 예정입니다. - 상기 '10. 1일 매수 주문수량 한도'는 '증권의 발행 및 공시 등에 관한 규정' 제5-5조 제1항 제2호에 따라 [①과 ②중 많은 수량]과 ③을 비교하여 적은 수량을 한도로 합니다. ① 취득신고주식수의 10% : 195,488주② 이사회 결의일 전일로부터 1개월간 일평균거래량의 25% : 30,017주③ 발행주식총수의 1% : 1,207,491주
| 【Treasury Share Acquisition Limit】 |
| Item | Amount |
| 1. Distributable Profit Limit under the Commercial Act as of Prior Fiscal Year-End | a. Net Assets | 2,418,076,784,795 |
| b. Share Capital | 62,239,087,500 |
| C. Sum of Capital Reserve and Legal Reserve Accumulated through Prior Fiscal Year | 674,161,539,175 |
| D. Unrealized Gains Prescribed by Presidential Decree | 13,496,914,979 |
| Subtotal (A-B-C-D) | 1,668,179,243,141 |
| 2. Treasury Share Acquisition Amount Since Prior Fiscal Year-End | 0 |
| 3. Dividends Resolved at the AGM Since Prior Fiscal Year-End and Related Legal Reserve | 26,316,227,300 |
| 4. Quarterly/Interim Dividends Resolved by the Board Since Prior Fiscal Year-End and Related Legal Reserve | 0 |
| 5. Trust Contract Amount | 0 |
| 6. Acquisition Cost of Treasury Shares Disposed Since Prior Fiscal Year-End (Moving Average Method) | 0 |
| Treasury share acquisition limit (1-2-3-4-5+6) | 1,641,863,015,841 |
- 상기 '금액'은 '원'단위로 작성하였습니다.- 상기 '1. 직전사업연도 말 현재 상법상 배당가능이익 한도'는 2025-12-31 별도재무제표 기준으로 산정하였습니다.
| 【Treasury Shares Held Before Acquisition Resolution】 |
| Acquisition method | Type of Shares | Beginning quantity | Change in quantity | Ending quantity | Remarks |
| Acquired (+) | Disposed (-) | Retired (-) |
| Acquisition within distributable profits | Direct acquisition | Direct On-Market Acquisition | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Direct OTC acquisition | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Tender offer | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Subtotal (a) | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Acquisition under trust agreement | Shares held by trustee | Common Shares | - | - | - | - | - | - |
| Other Shares | - | - | - | - | - | - |
| Shares held in kind | Common Shares | 2,129,750 | - | - | 1,000,000 | 1,129,750 | - |
| Other Shares | - | - | - | - | - | - |
| Subtotal (b) | Common Shares | 2,129,750 | - | - | 1,000,000 | 1,129,750 | - |
| Other Shares | - | - | - | - | - | - |
| Other acquisitions (c) | Common Shares | 137 | - | - | - | 137 | - |
| Other Shares | - | - | - | - | - | - |
| Total (a+b+c) | Common Shares | 2,129,887 | - | - | 1,000,000 | 1,129,887 | - |
| Other Shares | - | - | - | - | - | - |
- 상기 '기초수량'은 2026-01-01 시점 보유 수량이며, '기말수량'은 공시서류작성기준일 2026-11-10 현재 보유 수량입니다.